XCUR (Exicure, Inc. Common Stock) Stock Analysis - Analyst Ratings

Exicure, Inc. Common Stock (XCUR) is a publicly traded Healthcare sector company. As of May 21, 2026, XCUR trades at $2.76 with a market cap of $19.50M and a P/E ratio of -3.70. XCUR moved +2.08% today. Year to date, XCUR is -46.89%; over the trailing twelve months it is -70.69%. Its 52-week range spans $2.15 to $36.00. Rallies surfaces XCUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate XCUR?

The average price target is $0.00.

XCUR Key Metrics

Key financial metrics for XCUR
MetricValue
Price$2.76
Market Cap$19.50M
P/E Ratio-3.70
EPS$-0.79
Dividend Yield0.00%
52-Week High$36.00
52-Week Low$2.15
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-4.95M
Gross Margin0.00%

XCUR Analyst Consensus

XCUR analyst coverage data. Average price target: $0.00.

Latest XCUR News

Recent XCUR Insider Trades

  • Exicure HiTron Inc. sold 258.37K (~$1.16M) on Jan 21, 2026.
  • Exicure HiTron Inc. sold 734.75K (~$3.31M) on Jan 16, 2026.
  • Exicure HiTron Inc. sold 741.27K (~$3.34M) on Jan 7, 2026.

Common questions about XCUR

What do analysts rate XCUR?
The average price target is $0.00.
Does Rallies show XCUR price targets?
Yes. Rallies tracks XCUR analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is XCUR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XCUR. It does not provide personalized investment advice.
XCUR

XCUR